|
1
|
Sehgal VN, Srivastava G and Sardana K:
Erythroderma/exfoliative dermatitis. A synopsis. Int J Dermatol.
43:39–47. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rym BM, Mourad M, Bechir Z, Dalenda E,
Faika C, Iadh AM and Amel BO: Erythroderma in adults, A report of
80 cases. Int J Dermatol. 44:731–5. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dua R, Sindhwani G and Rawat J:
Exfoliative dermatitis to all four first line oral anti-tubercular
drugs. Indian J Tuberc. 57:53–6. 2010.PubMed/NCBI
|
|
4
|
Jaisuresh K: Pyrazinamide-induced
exfoliative dermatitis in a patient on hemodialysis: A rare
complication. Case Rep Nephrol. 2013:3872932013.PubMed/NCBI
|
|
5
|
Rabbat JC, Lin MY and Moy JN: Induction of
tolerance in a patient with a history of exfoliative dermatitis to
trimethoprim-sulfamethoxazole. Ann Allergy Asthma Immunol.
109:360–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O'Neill PG, Rajan N, Charlat ML and Bolli
R: Captopril-related exfoliative dermatitis. Tex Med. 85:40–41.
1989.
|
|
7
|
Sawaishi Y, Komatsu K, Takeda O, Tazawa Y,
Takahashi I, Hayasaka K and Takada G: A case of tubulo-interstitial
nephritis with exfoliative dermatitis and hepatitis due to
phenobarbital hypersensitivity. Eur J Pediatr. 151:69–72. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ipek Y, Hulya D and Melih A: Disseminated
exfoliative dermatitis associated with all-transretinoic Acid in
the treatment of acute promyelocyticleukemia. Case Rep Med.
2012:2361742012.PubMed/NCBI
|
|
9
|
Wedemeyer RS and Blume H: Pharmacokinetic
drug interaction profiles of proton pump inhibitors: An update.
Drug Saf. 37:201–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Watson C, Zhu L, Guan S, Machen TE and
Forte JG: Reaction of proton pump inhibitors with model peptides
results in novel products. J Pharmacol Sci. 122:213–22. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ramírez E, Cabañas R, Laserna LS, Fiandor
A, Tong H, Prior N, Calderón O, Medrano N, Bobolea I, Frías J and
Quirce S: Proton pump inhibitors are associated with
hypersensitivity reactions to drugs in hospitalized patients, A
nested case-control in a retrospective cohort study. Clin Exp
Allergy. 43:344–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang YS: Hypersensitivity reactions to
proton pump inhibitors. Curr Opin Allergy Clin Immunol. 12:348–353.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hood W, McJunkin B, Warnock A, Girme A,
Smith N and Robinson B: Proton pump inhibitor prescribing and costs
in a large outpatient clinic. W V Med J. 110:16–21. 2014.PubMed/NCBI
|
|
14
|
Mouterde O, Bellaïche M, Dumant C and
Mallet E: Gastroesophageal reflux and proton pump inhibitors,
Panacea or prescription abuse? Arch Pediatr. 17:739–740. 2010.(In
French). View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akram F, Huang Y, Lim V, Huggan PJ and
Merchant RA: Proton pump inhibitors, Are we still prescribing them
without valid indications? Australas Med J. 7:465–470. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reimer C and Bytzer P: Adverse events
associated with long-term use of proton pump inhibitors. Ugeskr
Laeger. 174:2289–2293. 2012.(In Danish). PubMed/NCBI
|
|
17
|
Zhang D, Zhang Y, Liu M, Wang X, Yang M,
Han J and Liu H: Pharmacokinetics of lansoprazole and its main
metabolites after single and multiple intravenous doses in healthy
Chinese subjects. Eur J Drug Metab Pharmacokinet. 38:209–215. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Andersson T: Pharmacokinetics metabolism
and interactions of acid pump inhibitors. Focus on omeprazole,
lansoprazole and pantoprazole. Clin Pharmacokinet. 31:9–28. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zvyaga T, Chang SY, Chen C, Yang Z,
Vuppugalla R, Hurley J, Thorndike D, Wagner A, Chimalakonda A and
Rodrigues AD: Evaluation of six proton pump inhibitors as
inhibitors of various human cytochromes P450: Focus on cytochrome
P450 2C19. Drug Metab Dispos. 40:1698–1711. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kirwan CJ, MacPhee IA, Lee T, Holt DW and
Philips BJ: Acute kidney injury reduces the hepatic metabolism of
midazolam in critically ill patients. Intensive Care Med. 38:76–84.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Philips BJ, Lane K, Dixon J and Macphee I:
The effects of acute renal failure on drug metabolism. Expert Opin
Drug Metab Toxicol. 10:11–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
